Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet)

Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):e2102054118. doi: 10.1073/pnas.2102054118.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines